Twelve adult patients with non-leukaemic lymphoblastic lymphoma were treated with combination chemotherapy and central nervous system prophylaxis according to the protocol developed at Stanford University. Despite strict adherence to the Stanford protocol, 4 of 12 patients relapsed in the CNS, all with meningeal disease. Only four of the 12 patients are in continuing complete remission 6 to 88 months from the completion of induction therapy. These results are inferior to those previously reported for this regimen, and fail to confirm the high rate of control of CNS disease.
|Original language||English (US)|
|Number of pages||3|
|Journal||Annals of Oncology|
|Publication status||Published - Dec 1 1992|
- Lymphoblastic lymphoma
ASJC Scopus subject areas